155 related articles for article (PubMed ID: 37920970)
1. A tetrasulfide bond-bridged mesoporous organosilica-based nanoplatform for triple-enhanced chemodynamic therapy combined with chemotherapy and H
Liu M; Xu H; Zhou F; Gong X; Tan S; He Y
J Mater Chem B; 2023 Nov; 11(45):10822-10835. PubMed ID: 37920970
[TBL] [Abstract][Full Text] [Related]
2. A multivalent polyphenol-metal-nanoplatform for cascade amplified chemo-chemodynamic therapy.
Li S; Zhao Y; Ma W; Wang D; Liu H; Wang W; Peng D; Yu CY; Wei H
Acta Biomater; 2024 Jan; 173():389-402. PubMed ID: 37967695
[TBL] [Abstract][Full Text] [Related]
3. H
Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
[TBL] [Abstract][Full Text] [Related]
4. Surface curvature-induced oriented assembly of sushi-like Janus therapeutic nanoplatform for combined chemodynamic therapy.
Ma Y; Liu M; Hou M; Kou Y; Wang W; Zhao T; Li X
J Nanobiotechnology; 2023 Nov; 21(1):425. PubMed ID: 37968644
[TBL] [Abstract][Full Text] [Related]
5. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion.
Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S
J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic Yolk-Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic Therapy of Cancer.
Pan Y; Zhu Y; Xu C; Pan C; Shi Y; Zou J; Li Y; Hu X; Zhou B; Zhao C; Gao Q; Zhang J; Wu A; Chen X; Li J
ACS Nano; 2022 Nov; 16(11):19038-19052. PubMed ID: 36315056
[TBL] [Abstract][Full Text] [Related]
7. Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy.
Fu LH; Wan Y; Qi C; He J; Li C; Yang C; Xu H; Lin J; Huang P
Adv Mater; 2021 Feb; 33(7):e2006892. PubMed ID: 33394515
[TBL] [Abstract][Full Text] [Related]
8. H
Tang Z; Jiang S; Tang W; He Q; Wei H; Jin C; Wang S; Zhang H
Mol Pharm; 2023 Mar; 20(3):1717-1728. PubMed ID: 36809003
[TBL] [Abstract][Full Text] [Related]
9. Hollow mesoporous MnO
He H; Yang Q; Li H; Meng S; Xu Z; Chen X; Sun Z; Jiang B; Li C
Mikrochim Acta; 2021 Mar; 188(4):141. PubMed ID: 33774694
[TBL] [Abstract][Full Text] [Related]
10. Biomimetic nanoplatform with H
Fu LH; Wu XY; He J; Qi C; Lin J; Huang P
Acta Biomater; 2023 May; 162():44-56. PubMed ID: 36934891
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional CuFe
Chen N; Li Y; Li H; Wang Y; Zeng Y; Zhang M; Pan Z; Chen Z; Liang W; Huang J; Zhang K; Liu X; He Y
Colloids Surf B Biointerfaces; 2023 Sep; 229():113445. PubMed ID: 37441838
[TBL] [Abstract][Full Text] [Related]
13. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H
Tian H; Zhang M; Jin G; Jiang Y; Luan Y
J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905
[TBL] [Abstract][Full Text] [Related]
14. Facile Synthesis of Fe
Qi C; Wang W; Wang P; Cheng H; Wang X; Gong B; Xie A; Shen Y
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807249
[TBL] [Abstract][Full Text] [Related]
15. Amorphous Ultra-Small Fe-Based Nanocluster Engineered and ICG Loaded Organo-Mesoporous Silica for GSH Depletion and Photothermal-Chemodynamic Synergistic Therapy.
Li J; Tian H; Zhu F; Jiang S; He M; Li Y; Luo Q; Sun W; Liu X; Wang P
Adv Healthc Mater; 2022 Nov; 11(21):e2201986. PubMed ID: 36106722
[TBL] [Abstract][Full Text] [Related]
16. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
17. A ROS storm generating nanocomposite for enhanced chemodynamic therapy through H
Li Y; Wang J; Zhu T; Zhan Y; Tang X; Xi J; Zhu X; Zhang Y; Liu J
Nanoscale; 2024 May; 16(17):8479-8494. PubMed ID: 38590261
[TBL] [Abstract][Full Text] [Related]
18. Tumor Microenvironment-Activated Theranostics Nanozymes for Fluorescence Imaging and Enhanced Chemo-Chemodynamic Therapy of Tumors.
Zhao DH; Li CQ; Hou XL; Xie XT; Zhang B; Wu GY; Jin F; Zhao YD; Liu B
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55780-55789. PubMed ID: 34787410
[TBL] [Abstract][Full Text] [Related]
19. Intelligent Nanoplatform with Multi Therapeutic Modalities for Synergistic Cancer Therapy.
Shao L; Hu T; Fan X; Wu X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
ACS Appl Mater Interfaces; 2022 Mar; 14(11):13122-13135. PubMed ID: 35286061
[TBL] [Abstract][Full Text] [Related]
20. Open-Source and Reduced-Expenditure Nanosystem with ROS Self-Amplification and Glutathione Depletion for Simultaneous Augmented Chemodynamic/Photodynamic Therapy.
Chen M; Zhao S; Zhu J; Feng E; Lv F; Chen W; Lv S; Wu Y; Peng X; Song F
ACS Appl Mater Interfaces; 2022 May; 14(18):20682-20692. PubMed ID: 35500204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
